53 Biggest Movers From Yesterday

Gainers

• Longeveron Inc. LGVN shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with mild Alzheimer's disease in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
• SAB Biotherapeutics, Inc. SABS jumped 44.6% to settle at $3.76. SAB Biotherapeutics posted a FY21 net loss of $17.1 million.
• Integrated Media Technology Limited IMTE climbed 38.3% to settle at $31.14.
• Jaguar Health, Inc. JAGX jumped 32.3% to close at $0.7085 after the company announced an agreement granting Quadri Pharmaceuticals for exclusive promotional, commercialization and distribution rights for specified human indications of crofelemer in the Middle East.
• Icosavax, Inc. ICVX shares gained 32.1% to close at $7.04 following Q4 results.
• CPS Technologies Corporation CPSH gained 27.1% to close at $5.21.
• Trevena, Inc. TRVN surged 24.6% to close at $0.5499 after the company reported Q4 earnings results and entered into a royalty-based financing agreement of up to $40 million with an affiliate of R-Bridge Healthcare Fund.
• Clovis Oncology, Inc. CLVS jumped 22.4% to close at $2.02 as the company announced positive topline data from the monotherapy arm of Phase 3 ATHENA-MONO trial of Rubraca (Rucaparib) as first-line maintenance treatment in ovarian cancer.
• iSpecimen Inc. ISPC gained 20.1% to close at $5.37.
• TMC the metals company Inc. TMC jumped 19.4% to settle at $2.59 following circulation of a letter from the company's CEO to a member of the Senate Committee on Energy and Natural Resources.
• DURECT Corporation DRRX gained 17.5% to close at $0.6699.
• Inspirato Incorporated ISPO rose 16.3% to close at $9.94.
• Vertex Energy, Inc. VTNR gained 15.5% to close at $9.94.
• Crinetics Pharmaceuticals, Inc. CRNX jumped 15.5% to settle at $21.95 after the company reported Q4 earnings results and top-line results from its Phase 1 clinical study of CRN04777.
• IZEA Worldwide, Inc. IZEA climbed 15.3% to close at $1.66 after the company reported Q4 EPS results up from last year and better-than-expected sales results.
• Nano-X Imaging Ltd. NNOX climbed 15.1% to close at $10.84 after the company reported better-than-expected Q4 EPS and sales results.
• Creative Medical Technology Holdings, Inc. CELZ gained 15% to close at $3.90 after the company announced it signed a Master Collaboration Agreement with the University of Miami to accelerate development of its ImmCelz Supercharged Autologous Immunotherapy Platform.
• NextPlat Corp NXPL jumped 15% to close at $3.06.
• RCM Technologies, Inc. RCMT climbed 14.9% to close at $9.86 after the company reported Q4 results.
• Vector Group Ltd. VGR surged 13.6% to close at $12.04 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $12 to $16.
• American Resources Corporation AREC jumped 11.7% to close at $2.57.
• Local Bounti Corporation LOCL gained 11.6% to close at $8.49. Local Bounti recently agreed to acquire California-based complementary indoor farming company Hollandia Produce Group Inc, which operates under the name Pete's, for $122.5 million.
• BioAtla, Inc. BCAB climbed 8.9% to close at $5.00.

Don’t forget to check out our premarket coverage here .

Losers

• Motorsport Games Inc. MSGM fell 35.9% to close at $1.32 on Thursday after the company reported Q4 financial results. Canaccord Genuity and Benchmark downgraded the stock.
• Missfresh Limited MF fell 29.4% to settle at $0.9042.
• Clarus Therapeutics Holdings, Inc. CRXT dipped 28.4% to close at $1.49 after the company reported Q4 earnings results.
• Sky Harbour Group Corporation SKYH fell 28% to close at $14.92.
• Acutus Medical, Inc. AFIB fell 28% to settle at $1.39 after the company reported worse-than-expected Q4 EPS results and issued Q1 sales guidance below analyst estimates.
• SOS Limited SOS dipped 27.3% to close at $0.5366 after the company announced pricing of a roughly $20 million registered direct offering.
• Arcadia Biosciences, Inc. RKDA shares dipped 25.9% to settle at $1.40 as the company reported fourth-quarter revenue declined 70% year-over-year to $2.17 million, missing the consensus of $3.33 million.
• UiPath Inc. PATH shares fell 25.7% to close at $21.59. UiPath reported upbeat results for its fourth quarter on Wednesday, but issued weak sales guidance.
• Sharecare, Inc. SHCR dropped 25.2% to close at $2.47 after the company reported worse-than-expected Q4 sales results and issued Q1 and FY22 sales guidance below estimates.
• Rail Vision Ltd. RVSN dropped 25% to close at $3.09 on Thursday as the company priced its IPO at $4.13 per unit.
• InflaRx N.V. IFRX fell 23.4% to close at $1.83 as the company announced topline data from Phase 3 part of Phase 2/3 PANAMO study of vilobelimab in critically ill COVID-19 patients.
• Meiwu Technology Company Limited WNW dropped 22.2% to close at $0.8797.
• Oxbridge Re Holdings Limited OXBR shares fell 21.3% to close at $5.47
• after the company reported results for the fourth quarter.
• Hillstream BioPharma, Inc. HILS shares fell 21.2% to close at $1.60 after jumping 39% on Wednesday.
• Terran Orbital Corporation LLAP dropped 21% to close at $6.88.
• Genetron Holdings Limited GTH fell 20.9% to close at $2.19.
• Cyren Ltd. CYRN dipped 20.6% to close at $5.05.
• VNET Group, Inc. VNET dipped 18.1% to close at $1.83. VNET Group posted Q4 loss of $0.24 per share.
• Locafy Limited LCFY fell 16.4% to close at $2.3405.
• 111, Inc. YI dropped 16.4% to settle at $2.66.
• Stronghold Digital Mining, Inc. SDIG dipped 16.1% to close at $5.85.
• Synthetic Biologics, Inc. SYN fell 15.1% to close at $0.2853.
• DiDi Global Inc. DIDI fell 15% to close at $2.50.
• NRx Pharmaceuticals, Inc. NRXP dropped 14.1% to close at $2.45 after the company reported FY21 earnings results. The company also reported its nebulized form of aviptadil in the I-SPY COVID Trial has been stopped.
• Revelation Biosciences, Inc. REVB fell 13.6% to close at $1.14. Revelation Biosciences recently said its Phase 2b viral challenge study to evaluate the efficacy of intranasal REVTx-99a did not meet its primary endpoint.
• Akebia Therapeutics, Inc. AKBA dropped 13.4% to close at $0.7179. Akebia Therapeutics recently said the FDA issued a complete response letter to the company's New Drug Application for vadadustat.
• Vyant Bio, Inc. VYNT shares fell 11.2% to close at $1.43. Vyant Bio shares jumped over 19% on Wednesday after the company announced a strategic collaboration to discover therapeutics to treat Parkinson's Disease and reported Q4 earnings results.
• U.S. Well Services, Inc. USWS fell 9.1% to close at $1.10 as the company posted a loss for its fourth quarter, while sales missed estimates.
• Auddia Inc. AUUD dropped 8.9% to close at $2.04.
• China SXT Pharmaceuticals, Inc. SXTC fell 7.4% to close at $0.28.